Long-term Durability of TAVR Encouraging: NOTION, UK TAVI Long-term Durability of TAVR Encouraging: NOTION, UK TAVI

Transcatheter valve replacement is increasingly being used as an alternative to surgical replacement in severe aortic stenosis, but how durable is it? Two studies provide reassuring findings.Medscape Medical News
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Cardiology News Source Type: news

Related Links:

Raj Makkar, MD, discusses the PARTNER-3 and Evolut trials of transcatheter aortic valve replacement in low-surgical-risk patients and his registry data on TAVR for bicuspid aortic stenosis at ACC.19.theheart.org on Medscape
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Cardiology Commentary Source Type: news
Authors: Kim C, Hong MK Abstract Transcatheter aortic valve implantation (TAVI) has been accepted as one of primary options for treatment of symptomatic severe aortic stenosis. Although TAVI has been predominantly used for patients at high risk or with old age who were not considered optimal candidates for surgical aortic valve replacement (SAVR), its indication is now expanding toward low risk profile and younger age. Many clinical trials are now ongoing to test the possibility of TAVI for use in patients even with uncharted indications who are not eligible for SAVR in current guidelines but may benefit from valve...
Source: Korean Circulation Journal - Category: Cardiology Tags: Korean Circ J Source Type: research
(MedPage Today) -- Study supports timely aortic valve replacement in asymptomatic patients
Source: MedPage Today Cardiovascular - Category: Cardiology Source Type: news
ConclusionIn this prospective series of CLF-AS, patients with very low LVEF or with no flow reserve benefit from AVR.
Source: Archives of Cardiovascular Diseases Supplements - Category: Cardiology Source Type: research
Publication date: April 2019Source: Archives of Cardiovascular Diseases Supplements, Volume 11, Issue 2Author(s): M.S. Annabi, J. Bergler-Klein, A. Dahou, I.G. Burwash, G. Ong, L. Tastet, E. Guzzetti, S. Orwat, H. Baumgartner, P.E. Bartko, J. Mascherbauer, G. Mundigler, J. Cavalcante, H.B. Ribeiro, J. Rodes-Cabau, P. Pibarot, M.A. ClavelBackgroundIn low-flow, low gradient aortic stenosis (LFLG-AS i.e. with low left ventricular [LV] ejection fraction), there is no data on the value of the clinical activation ratios of B-type natriuretic peptide (BNP-ratio) versus aminoterminal-proBNP (NT-proBNP-ratio) as surrogates of LV im...
Source: Archives of Cardiovascular Diseases Supplements - Category: Cardiology Source Type: research
This study included 508 patients (mean age 75 ± 11 years) with MAS (aortic valve area [AVA] between 1 and 1.5 cm2, mean AVA 1.2 ± 0.15 cm2). Patients were mostly (86.4%) asymptomatic or minimally symptomatic, 78.3% had hypertension, 36.2% were diabetics and 48.3% had dyslipidemia. Survival of MAS patients was compared with the expected survival of age- and sex-matched individuals of the general population.ResultsDuring follow-up, 113 patients (22.2%) underwent aortic valve replacement (AVR) for severe aortic stenosis. The mean time between inclusion and surgery was 37 ± 22...
Source: Archives of Cardiovascular Diseases Supplements - Category: Cardiology Source Type: research
ConclusionPreoperative ECG Strain was associated with higher risk of ME onset after TAVR for severe AS.
Source: Archives of Cardiovascular Diseases Supplements - Category: Cardiology Source Type: research
Publication date: April 2019Source: Archives of Cardiovascular Diseases Supplements, Volume 11, Issue 2Author(s): M.S. Annabi, A. Dahou, I.G. Burwash, P.E. Bartko, J. Bergler-Klein, J. Mascherbauer, G. Mundigler, S. Orwat, H. Baumgartner, J. Cavalcante, H.B. Ribeiro, J. Rodes-Cabau, M.A. Clavel, P. PibarotBackgroundThe survival benefit of surgical (SAVR) or transcatheter (TAVR) aortic valve replacement over conservative management (ConsRx) remains unclear in patients with low-flow, low-gradient (LFLG) aortic stenosis (AS).Method476 LFLG AS patients (mean age 75 ± 10 yo, 71% males, 71% classical and 29% par...
Source: Archives of Cardiovascular Diseases Supplements - Category: Cardiology Source Type: research
Publication date: April 2019Source: Archives of Cardiovascular Diseases Supplements, Volume 11, Issue 2Author(s): A. Coppin, H. Ridon, C. Seunes, S. Mouton, E. Woitrain, M. Koussa, B. Jegou, F. Pontana, T. Modine, A. Coisne, D. MontaigneIntroductionQuantitative assessment of right ventricular (RV) function is difficult with 2D-echocardiography (2D-TTE) and changes in RV longitudinal parameters are surprisingly not predictive of cardiovascular events after surgical Aortic Valve Replacement (SAVR).ObjectiveWe aimed at investigating peri-operative evolution of both RV longitudinal parameters and RV global function (assessed b...
Source: Archives of Cardiovascular Diseases Supplements - Category: Cardiology Source Type: research
This study sought to determine outcomes in patients with severe, asymptomatic aortic stenosis (AS), stratified by treatment recommendation.MethodsBetween January 2005 and December 2013, 4,998 patients had severe AS by echocardiography, of whom 308 were identified as asymptomatic by medical record review. Five patients were deemed inoperable, and 38 were lost to follow-up. Of the remaining 265 patients, aortic valve replacement (AVR) was recommended in 104, and watchful waiting (WW) was recommended in 161. Probabilities of undergoing surgery and of death from recommendation date were estimated using a multistate model. Cox ...
Source: The Annals of Thoracic Surgery - Category: Cardiovascular & Thoracic Surgery Source Type: research
More News: Aortic Stenosis | Cardiology | Health | Heart | Heart Valve Surgery | Study